GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                            
                            
                            
                                 Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: SC83288 is an amicarbalide derivative and the clinical development candidate for this novel antimalarial chemotype [2].  
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Duffey M, Sanchez CP, Lanzer M. (2018)
                                         Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum. Malar J, 17 (1): 121. [PMID:29558913]  | 
                                                                
| 
                                                                         2. Pegoraro S, Duffey M, Otto TD, Wang Y, Rösemann R, Baumgartner R, Fehler SK, Lucantoni L, Avery VM, Moreno-Sabater A et al.. (2017)
                                         SC83288 is a clinical development candidate for the treatment of severe malaria. Nat Commun, 8: 14193. [PMID:28139658]  |